Denarda Dangaj Laniti

12PUBLICATIONS
136CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 01, 2026
Spatially Defined Cellular Niches Forged by Tumor-Intrinsic MHCII Redefine Immune Competence in Ovarian Cancer.

|Apr 17, 2026
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

|Apr 13, 2026
Rethinking ovarian cancer III: the past decade and future directions.

Frances R Balkwill, Céline M Laumont, Nikki Burdett

|Nov 24, 2025
Tissue specificity and chromosomal alterations shape divergent immune programs in HRD tumors.

Doga C Gulhan, David Barras, Marco Mina

|Mar 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study.

Susana Banerjee, Eleonora Ghisoni, Anita Wolfer

|Nov 28, 2024
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity.

Anais Elewaut, Guillem Estivill, Felix Bayerl

Pageof 2

Frequent Collaborators

6 joint publications

David Barras

6 joint publications

George Coukos

5 joint publications

Lana Kandalaft

5 joint publications

Fabrizio Benedetti